MEDICAL CANNABIS —
1129. Hon AARON STONEHOUSE to the parliamentary secretary
representing the Minister for Health:
I refer the minister to recent
changes to the regulations relating to the prescription of medicinal cannabis
in New South Wales.
(1) Is it true
that, as of these changes being implemented, a doctor in New South Wales need
apply for authorisation from the New South Wales Department of Health only if
he or she is proposing to prescribe medicinal cannabis to a patient who is
either drug dependant or under the age of 16, while all other patient applications now go directly to the Therapeutic
Goods Administration for special access scheme approval?
(2) Given that we
currently require both departmental and TGA sign-off for all applications here
in Western Australia, does the McGowan government have any plans to introduce
similar regulatory changes; and, if not, why not?
I thank the honourable member for
some notice of the question.
(2) Changes in
New South Wales and the current processes for approval in other states and
territories will be considered as part of the ongoing review by the Department
of Health into the regulation of the prescribing of medicinal cannabis in Western